Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Social Phobia

Treatments: Drug: Paroxetine

Study type: Observational

Funder types: Industry

Identifiers

NCT01376271

114102

Details and patient eligibility

About

The study is designed to evaluate the safety and efficacy of paroxetine on the long-term use in Japanese Social Anxiety Disorder (SAD) subjects.

Enrollment: 600 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who are diagnosed as having SAD
• Subjects who are expected to use paroxetine tablets for the first time

Exclusion criteria

• Subjects taking pimozide
• Subjects taking monoamine oxidase (MAO) inhibitor or within two weeks after discontinuation of MAO inhibitor
• Subjects with hypersensitivity to paroxetine

Trial design

600 participants in 1 patient group

Subjects prescribed paroxetine tablets

Description:

Subjects with SAD prescribed paroxetine tablets during study period

Treatment:

Drug: Paroxetine